These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26946218)

  • 1. Operational Characteristics of Linear Concentration-QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies.
    Garnett C; Needleman K; Liu J; Brundage R; Wang Y
    Clin Pharmacol Ther; 2016 Aug; 100(2):170-8. PubMed ID: 26946218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Phase 1 study design on estimation of QT interval prolongation risk using exposure-response analysis.
    Tsamandouras N; Duvvuri S; Riley S
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):605-616. PubMed ID: 31664592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific white paper on concentration-QTc modeling.
    Garnett C; Bonate PL; Dang Q; Ferber G; Huang D; Liu J; Mehrotra D; Riley S; Sager P; Tornoe C; Wang Y
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):383-397. PubMed ID: 29209907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?".
    Darpo B; Sarapa N; Garnett C; Benson C; Dota C; Ferber G; Jarugula V; Johannesen L; Keirns J; Krudys K; Ortemann-Renon C; Riley S; Rogers-Subramaniam D; Stockbridge N
    Ann Noninvasive Electrocardiol; 2014 Jan; 19(1):70-81. PubMed ID: 24372708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes.
    Malik M; Garnett C; Hnatkova K; Johannesen L; Vicente J; Stockbridge N
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):491-503. PubMed ID: 29651591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study Design Parameters Affecting Exposure Response Analysis of QT Data: Results From Simulation Studies.
    Ferber G; Sun Y; Darpo B; Garnett C; Liu J
    J Clin Pharmacol; 2018 May; 58(5):674-685. PubMed ID: 29420838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a thorough QTc study necessary? The role of modeling and simulation in evaluating the QTc prolongation potential of drugs.
    Rohatagi S; Carrothers TJ; Kuwabara-Wagg J; Khariton T
    J Clin Pharmacol; 2009 Nov; 49(11):1284-96. PubMed ID: 19734373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates.
    Gaitonde P; Huh Y; Darpo B; Ferber G; Heimann G; Li J; Lu K; Sebastien B; Tsai K; Riley S
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):617-626. PubMed ID: 31667657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).
    Chiang AY; Bass AS; Cooper MM; Engwall MJ; Menton RG; Thomas K
    J Pharmacol Toxicol Methods; 2007; 56(2):95-102. PubMed ID: 17588780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-QTc analysis for single arm studies.
    Orihashi Y; Ohwada S; Kumagai Y
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):203-211. PubMed ID: 33512637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study.
    Ferber G; Lorch U; Täubel J
    Biomed Res Int; 2015; 2015():293564. PubMed ID: 26509147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    J Pharmacol Toxicol Methods; 2015; 72():1-10. PubMed ID: 25556117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and impact of hysteresis when evaluating a drug's QTc effect using concentration-QTc analysis.
    Ferber G; Darpo B; Garnett C; Huang D; Marathe DD; Sun Y; Liu J
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):187-202. PubMed ID: 33118135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
    Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the precision of QT measurements.
    Darpo B; Fossa AA; Couderc JP; Zhou M; Schreyer A; Ticktin M; Zapesochny A
    Cardiol J; 2011; 18(4):401-10. PubMed ID: 21769821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early QT assessment--how can our confidence in the data be improved?
    Darpo B; Garnett C
    Br J Clin Pharmacol; 2013 Nov; 76(5):642-8. PubMed ID: 23278510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug response hysteresis in the concentration-QTc analysis of early clinical trials.
    Li H; Tong B; Hosmane B; Chiu YL
    J Biopharm Stat; 2021 Sep; 31(5):705-722. PubMed ID: 34224329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.